Medline revenue and financials
$35.55Change from previous close: −0.70%Absolute change: −$0.25
In the fiscal year ended December 2025, Medline reported revenue of $28.43B (+11.47% year over year). Net income was $1.16B, a net margin of 4.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +11.47%
- 2025 vs 2024
- Net income growth
- −3.42%
- 2025 vs 2024
- Net margin
- 4.1%
- 2024: 4.7%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 39,350 | 39,014 | 38,484 | 36,883 | 36,428 | — | 35,978 | — |
| Current assets | 11,742 | 11,180 | 10,679 | 9,558 | 8,947 | — | 8,272 | — |
| Cash and equivalents | 2,327 | 2,236 | 1,939 | 952 | 580 | — | 199 | — |
| Short-term investments | 350 | — | — | — | — | — | — | — |
| Receivables | 3,940 | 3,674 | 3,533 | 3,425 | 3,340 | — | 3,219 | — |
| Inventory | 4,665 | 4,807 | 4,769 | 4,752 | 4,662 | — | 4,456 | — |
| Net property, plant and equipment | 4,697 | 4,758 | 5,210 | 4,690 | 4,672 | — | 4,979 | — |
| Goodwill | 8,072 | 8,076 | 8,079 | 8,069 | 8,069 | — | 8,065 | — |
| Other intangible assets | 13,538 | 13,717 | 13,893 | 14,068 | 14,246 | — | 14,559 | — |
| Long-term investments | — | — | — | 11.0 | 19.0 | — | 48.0 | — |
| Current liabilities | 2,710 | 2,536 | 2,490 | 2,612 | 2,351 | — | 2,440 | — |
| Accounts payable | 1,043 | 932 | 961 | 990 | 919 | — | 869 | — |
| Long-term debt | 12,548 | 12,495 | 12,484 | 16,501 | 16,501 | — | 16,416 | — |
| Total debt | — | — | 12,627 | — | — | — | — | — |
| Total liabilities | 20,273 | 19,665 | 19,198 | 20,109 | 19,844 | — | 19,820 | — |
| Total equity (incl. minority) | 19,077 | 19,349 | 19,286 | 16,774 | 16,584 | 16,158 | 16,158 | 16,744 |
| Retained earnings | 182 | 122 | -7.0 | — | — | — | — | — |
| Minority interest | 7,505 | 8,077 | 8,549 | — | — | — | — | — |